Provided by Tiger Trade Technology Pte. Ltd.

Verastem

7.55
+0.23003.14%
Post-market: 7.45-0.1000-1.32%19:30 EDT
Volume:1.73M
Turnover:13.30M
Market Cap:683.75M
PE:-3.13
High:7.91
Open:7.58
Low:7.54
Close:7.32
52wk High:10.82
52wk Low:3.43
Shares:90.56M
Float Shares:70.57M
Volume Ratio:0.83
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4143
EPS(LYR):-3.0223
ROE:-471.16%
ROA:-49.59%
PB:13.68
PE(LYR):-2.50

Loading ...

Amap Traffic Light Countdown Feature Expands Internationally, Aiming for Global Coverage

Deep News
·
May 20

GenFleet GFH375 wins China breakthrough status for KRAS G12D pancreatic cancer therapy

Reuters
·
May 18

Verastem price target lowered to $14 from $16 at Mizuho

TIPRANKS
·
May 14

Analysts’ Top Healthcare Picks: Verastem (VSTM), PDS Biotechnology (PDSB)

TIPRANKS
·
May 13

Verastem Oncology to present at RBC Global Healthcare Conference

Reuters
·
May 12

Verastem Inc Earnings Call Highlights Growth And Risk

TIPRANKS
·
May 09

Verastem (VSTM) Q4 Revenue Reaches US$17.5 Million Yet Heavy Losses Reinforce Bearish Views

Simply Wall St.
·
May 09

Verastem Is Maintained at Buy by BTIG

Dow Jones
·
May 08

Verastem price target raised to $18 from $16 at Alliance Global

TIPRANKS
·
May 08

H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)

TIPRANKS
·
May 08

Verastem Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Verastem Q1 adjusted loss narrows smaller than expected on recording revenue

Reuters
·
May 08

Verastem Q1 FY26 net loss narrows to $36.6 million; revenue turns to $18.7 million

Reuters
·
May 08

Verastem Q1 Adj. EPS $(0.43) Beats $(0.46) Estimate, Sales $18.671M Miss $21.579M Estimate

Benzinga Earnings
·
May 08

BRIEF-Verastem Q1 Net Income USD -36.591 Million

Reuters
·
May 08

Verastem Q1 Operating Expenses USD 63.568 Million

THOMSON REUTERS
·
May 08

Mizuho Securities Adjusts Verastem Price Target to $16 From $18, Maintains Outperform Rating

MT Newswires Live
·
Apr 30

Verastem Price Target Maintained With a $19.00/Share by BTIG

Dow Jones
·
Apr 23

Verastem Oncology to report quarterly results, host conference call and webcast

Reuters
·
Apr 23

Press Release: Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026

Dow Jones
·
Apr 23